Skip to content
Screener

Ensysce Biosciences, Inc. ENSC Q1 2026 earnings

Reported May 15, 2026 · After market close

Revenue$961.0KMiss by $39.0K
EPS-$0.52In line
Revenue estimate$1.0M
EPS estimate-$0.52

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$1.2M
EPS estimate-$0.19

FAQ

When did Ensysce Biosciences, Inc. report Q1 2026 earnings?
Ensysce Biosciences, Inc. (ENSC) reported Q1 2026 earnings on May 15, 2026 after market close.
What were Ensysce Biosciences, Inc.'s Q1 2026 revenue and EPS?
Ensysce Biosciences, Inc. reported revenue of $961.0K and eps of $-0.52 for Q1 2026.
Did Ensysce Biosciences, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.0M by $39.0K. EPS beat the consensus estimate of $-0.52 by $0.00.
How did Ensysce Biosciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.2% from $1.3M a year earlier and eps grew 62.6% from $-1.39.
Where can I find Ensysce Biosciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023810) and the 10-Q periodic report (0001493152-26-023811) directly on SEC EDGAR. The filing index links above go to sec.gov.